Biomaterial Database

How well does your PBM perform? 1999

R McCarthy

UI	MeSH Term	Description	Entries
D007356	Insurance, Pharmaceutical Services	Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.	Drug Benefit Plans,Drug Insurance,Prescription Insurance,Insurance, Pharmaceutic Services,Insurance, Pharmacy Services,Pharmaceutic Services Insurance,Pharmaceutical Services Insurance,Pharmacy Services Insurance,Drug Benefit Plan,Insurance, Drug,Insurance, Prescription,Plan, Drug Benefit,Plans, Drug Benefit
D008119	Lobbying	A process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization.	Lobbyings
D008329	Managed Care Programs	Health insurance plans intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as HEALTH MAINTENANCE ORGANIZATIONS and PREFERRED PROVIDER ORGANIZATIONS.	Case Management, Insurance,Insurance Case Management,Managed Health Care Insurance Plans,Managed Care,Care, Managed,Managed Care Program,Management, Insurance Case,Program, Managed Care,Programs, Managed Care
D003659	Decision Making, Organizational	The process by which decisions are made in an institution or other organization.	Organizational Decision Making
D004345	Drug Industry	That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.	Industries, Pharmaceutic,Industry, Drug,Industry, Pharmaceutic,Industry, Pharmaceutical,Pharmaceutical Industry,Drug Industries,Industries, Drug,Industries, Pharmaceutical,Pharmaceutic Industries,Pharmaceutic Industry,Pharmaceutical Industries
D006264	Health Benefit Plans, Employee	Health insurance plans for employees, and generally including their dependents, usually on a cost-sharing basis with the employer paying a percentage of the premium.	CHAMPUS,Employee Health Benefit Plans
D014481	United States	A country in NORTH AMERICA between CANADA and MEXICO.
D016527	Drug Costs	The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES).	Cost, Drug,Costs, Drug,Drug Cost
D017723	Drug Utilization Review	Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.	Utilization Review, Drug,Drug Utilization Evaluation,Drug-Use Review,Evaluation, Drug Utilization,Review, Drug Utilization,Review, Drug-Use,Drug Use Review,Drug Utilization Evaluations,Drug Utilization Reviews,Drug-Use Reviews,Evaluations, Drug Utilization,Review, Drug Use,Reviews, Drug Utilization,Reviews, Drug-Use,Utilization Evaluation, Drug,Utilization Evaluations, Drug,Utilization Reviews, Drug
D019468	Disease Management	A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)	Disease Managements,Management, Disease,Managements, Disease